Clinical Research

Collaborators from a number of international centers, led by the European Molecular Biology Laboratory-European Bioinformatics Institute, published their findings Wednesday in Nature. Using MRI scans, along with morphology and genetic data, they showed that this network of heart muscle fibers—known as the trabeculae—can influence the heart’s performance.

Thousands of MRI scans help experts understand 500-year-old heart mystery first described by Leonardo da Vinci

Artificial intelligence also played a large role in discovering how this intricate network of muscle fibers can influence health, experts explained in Nature.

August 19, 2020
The American College of Cardiology and American Heart Association have collaborated on a new update to the much-discussed 2021 chest pain guidelines. The American College of Emergency Physicians and Society for Cardiac Angiography and Interventions also contributed to the document.

'A missed opportunity': Statin use low among patients with peripheral artery disease

Researchers tracked statin use among patients with peripheral artery disease, cerebrovascular disease and coronary heart disease.

July 13, 2020

Another way work-related stress can impact your cardiovascular health

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.

April 28, 2020

Multimodality imaging uncovers ‘landmarks’ for peripheral arterial disease recovery

These new recovery milestones will allow clinicians to pinpoint whether or not a patient is responding to therapy or making the necessary strides toward rehabilitation.

March 2, 2020

Orsiro stent continues to outperform Xience at 3 years

Three-year data from the BIOFLOW-V trial, presented Feb. 23 at the 2020 CRT Congress in National Harbor, Md., reinforce the status of Biotronik’s Orsiro drug-eluting stent as superior to the popular Xience stent.

February 26, 2020

Study reveals similar 5-year outcomes for TAVR, SAVR

An analysis of PARTNER 2 data published in the New England Journal of Medicine Jan. 29 suggests five-year post-op outcomes are similar among heart patients who undergo either transcatheter or surgical aortic valve replacement.

January 30, 2020
pills-384846_960_720.jpg

Ticagrelor alone reduces bleeding risk after PCI, DAPT

Results from the late-breaking TWILIGHT trial suggest that, among high-risk patients who have undergone PCI and completed three months of dual antiplatelet therapy, it’s safer to continue treatment with ticagrelor alone rather than add aspirin to that cocktail.

October 9, 2019

TAVR linked to better long-term health status than SAVR

Patients with severe aortic stenosis who undergo TAVR enjoy a minor but significant sustained health benefit that isn’t mirrored in patients who opt for surgical AVR, according to research reported at TCT 2019 in San Francisco.

October 3, 2019